Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

MLEC vs ECX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLEC Captures Overall Composite Edge (40.8 SELL vs 52.4 HOLD), While ECX Leads 4–1 on Growth & Valuation Pillars

MLEC Overall Winner 6-Pillar Tally: MLEC 1 – 4 ECX (1 Tie) Matrix Metrics: MLEC 5 – 4 ECX

As of Nov 19, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over ECARX Holdings Inc. Class A (ECX) on higher Unified Composite conviction (40.8/100 SELL vs. 52.4/100 HOLD) after splitting the core matrix 5–4 (led by Profitability & Quality), while ECX wins 4–1 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus ECX at $0.69 (12.1x Forward P/E, -4.6% operating margin).

  • Composite vs. Pillar Nuance: While ECX currently prints a higher short-term Unified Composite Score (52.4/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (5–4 matrix metrics and 1–4 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -4.6% operating margin) and revenue trajectory (+948.3% vs. +9.5% YoY).
  • Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile ECX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MLEC vs ECX
MLEC NASDAQ Head-to-Head Winner
Moolec Science SA Ordinary Shares
Textile Mill Products
$0.85
-39.29% 1D
Market Cap $1.0M
TTM Revenue $7.8M
Forward P/E N/M
Beta / 30D Vol 0.05β · 208% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -30.9%), weak momentum, RSI 17
RSI-14: 16.8 · SMA20: $2.06 · SMA50: $4.58
ECX NASDAQ
ECARX Holdings Inc. Class A Ordinary shares
Services-Computer Integrated Systems Design
$0.69
-9.78% 1D
Market Cap $300.6M
TTM Revenue $902M
Forward P/E 12.1x
Beta / 30D Vol 0.44β · 122% Vol
Unified Composite Score
52.4 / 100 HOLD
Tech 50.0 Fund 53.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 37
RSI-14: 36.9 · SMA20: $0.81 · SMA50: $0.90

6-Pillar Scorecard Institutional Category Breakdown (MLEC 1 – 4 ECX)

Columns: Metric · MLEC · ECX
1. Valuation Multiples ECX
Forward P/E N/M 12.1x
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x 0.8x
2. Growth & Scale ECX
Revenue Growth (YoY) +948.3% +9.5%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $7.8M $902M
Market Cap $1.0M $300.6M
3. Profitability & Quality MLEC
Gross Margin -8.2% 15.3%
Operating Margin 0.0% -4.6%
Net Profit Margin 0.0% -7.4%
Return on Equity (ROE) -174.7% -2237.6%
4. Balance Sheet & Cash Flow ECX
Cash Generation (TTM) -$8.1M EBITDA -$22M EBITDA
Cash Flow Margin -103.1% EBITDA Mgn -2.4% EBITDA Mgn
Net Cash / Leverage $0.70 Book/Sh · -174.7% ROE $466M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ECX
OpEx & R&D Intensity N/A 19.9% of Rev ($180M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Auto Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MLEC (5) vs ECX (4)
Institutional Metric MLEC ECX Criterion Row Edge
Market Capitalization
Scale
$1.0M $300.6M Larger Scale ECX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M 12.1x Lower Multiple ECX
Revenue Growth (YoY)
Growth
+948.3% +9.5% Higher Growth MLEC
Operating Margin (TTM)
Profitability
0.0% -4.6% Higher Margin MLEC
Net Profit Margin
Profitability
0.0% -7.4% Higher Margin MLEC
Return on Equity (ROE)
Capital Efficiency
-174.7% -2237.6% Higher ROE MLEC
52-Week Range Position
Momentum
3% ($0–$23) 1% ($1–$2) Stronger Trend MLEC
Beta / 30D Volatility
Risk Regime
0.05β · 208% Vol 0.44β · 122% Vol Lower Realized Risk ECX
Unified Institutional Score
Composite Signal
40.8 / 100 (SELL) 52.4 / 100 (HOLD) Higher Composite ECX
Trailing 12M Revenue (USD)
Operating Scale
$7.8M $902M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-8.2% 15.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$8.1M EBITDA ($0.70 Book/Sh · -174.7% ROE) -$22M EBITDA ($466M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ECX +99.77 pp
MLEC: -82.11% · ECX: +17.66%
3M Horizon ECX +80.46 pp
MLEC: -87.8% · ECX: -7.34%
6M Horizon ECX +83.62 pp
MLEC: -91.8% · ECX: -8.18%
1Y Horizon MLEC +94.87 pp
MLEC: +52.58% · ECX: -42.29%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period MLEC Revenue ECX Revenue MLEC Op. Margin ECX Op. Margin Margin Leader
Q4 '24 $10M N/A -77.9% N/A MLEC
Q1 '25 N/A $670M N/A -14.7% ECX
Q2 '25 N/A $620M N/A -24.0% ECX
Q3 '25 N/A $880M N/A 1.5% ECX
Q4 '25 N/A $1.22B N/A 3.9% ECX
Q1 '26 N/A $530M N/A -9.9% ECX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MLEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ECX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ECX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MLEC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ECX Moat Profile Cyclical / Execution-Driven Positioning
Auto Parts Operator
Competes within the Auto Parts value chain with $300.6M market capitalization and -4.6% operating margin.
OpEx & R&D Reinvestment 19.9% of Rev ($180M)
90D Engineering Disclosures 0 Published

Investor FAQ MLEC vs ECX Key Questions & Quantitative Answers

As of Nov 19, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over ECARX Holdings Inc. Class A (ECX) on higher Unified Composite conviction (40.8/100 SELL vs. 52.4/100 HOLD) after splitting the core matrix 5–4 (led by Profitability & Quality), while ECX wins 4–1 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus ECX at $0.69 (12.1x Forward P/E, -4.6% operating margin). Composite vs. Pillar Nuance: While ECX currently prints a higher short-term Unified Composite Score (52.4/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (5–4 matrix metrics and 1–4 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -4.6% operating margin) and revenue trajectory (+948.3% vs. +9.5% YoY). Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile ECX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ECX leads the Growth & Scale pillar: MLEC posts +948.3% YoY revenue growth and +0.0% YoY earnings growth on $7.8M TTM revenue (-8.2% gross margin, 0.0% operating margin), compared with ECX at +9.5% YoY revenue growth and +0.0% YoY earnings growth on $902M TTM revenue (15.3% gross margin, -4.6% operating margin). Across the 6-period historical trajectory (Q4 '24 to Q1 '26), MLEC cumulative revenue shifted N/A while ECX shifted -20.9%. In operating R&D and SG&A reinvestment, MLEC deploys N/A (0 90-day corporate R&D disclosures) versus 19.9% of Rev ($180M) (0 disclosures) for ECX.

ECX screens cheaper on headline valuation multiples. MLEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-103.1% EBITDA margin), whereas ECX trades at 12.1x Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-2.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MLEC (-174.7% ROE) versus ECX (-2237.6% ROE) capital efficiency.

In options market volatility and institutional positioning, MLEC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 208% Vol realized risk). By comparison, ECX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 122% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.